Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
A single ascending dose, first-in-human phase 1 study to assess the safety and pharmacokinetic profile of LY3437943 was performed on 47 healthy participants (ClinicalTrials.gov, NCT03841630)
10.1001/jama.2021.15650 133 OhlK.TenbrockK.KippM
Lauterburg BH
The data were normalized to the first timepoint
Potential Risks and Side Effects of BPC-157 Lack of Long-Term Human Research The biggest concern surrounding BPC-157 is the lack of extensive human studies
In other words, helping someone lose weight is the higher goal, but the journey of weight loss must address organ health (heart, kidneys, eyes, liver, vascular, etc.), physical health (daily cardio and strength exercises), mental health (mood, thought patterns, coping skills), and ones spiritual health (connection with others, faith in a higher being, feelings of inclusion)
US$ 20.11
US$ 22.59
US$ 29.94
US$ 27.70
US$ 26.43
